Editor’s note

Diversifying beyond the US market

Read more

The fine line between reform and risk 

Read more

India Pharma’s new resilience mantras

Read more

Sun Pharma bets on Organon for its next wind 

Read more

Midst global headwinds, CDSCO cracks down on GLP-1 gold rush

Read more

Building India Pharma Inc’s innovation muscle

Read more

India-EU FTA offers new hope

Read more

Balancing protection and compliance

Read more

A biosimilar boost amid trade barriers

Read more

Will India pass the cough syrup trust test this time?

Read more